Cumberland Pharmaceuticals (CPIX) - Cash on Hand per Share

Cumberland Pharmaceuticals relies on the growth of government procurement of prescription drugs and the development of its GI portfolio. The balance is maintained through a combination of approved hospital drugs and new formulas. Stable demand for biotechnology makes the asset a defensive play against recessions. The cash per share metric confirms this data, recording a value of 5.33, which demonstrates the current solvency of the business.
Analytical breakdowns for Cumberland Pharmaceuticals

Cumberland Pharmaceuticals (CPIX) holds exclusive supply rights for intensive care units, which minimizes pricing risks and ensures a stable flow of liquidity. This metric is calculated by dividing total cash reserves by the number of shares outstanding, determining the actual "safety cushion" per share. Investors utilize this metric to assess the asset's intrinsic value and protect capital from volatility. Analyzing cash per share allows for tracking the dynamics of free resources without quarterly delays. Such an approach helps balance capital preservation with potential returns.